News Image

Nuwellis Announces 92% Survival in Children with Acute Kidney Injury (AKI), Fluid Overload or Congenital Kidney Failure Following Treatment with Aquadex®

Provided By GlobeNewswire

Last update: Sep 30, 2025

ULTRA-Peds Registry, the largest multi-center dataset of its kind, shows Aquadex therapy was well-tolerated in critically ill children, a population with extremely limited treatment options

Read more at globenewswire.com

NUWELLIS INC

NASDAQ:NUWE (11/28/2025, 7:51:28 PM)

2.44

+0.03 (+1.24%)



Find more stocks in the Stock Screener

Follow ChartMill for more